Disability in multiple sclerosis
Authors:
- 12 March 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 80 (11) , 1018-1024
Abstract
Objective: To create a reference table of disability outcomes in multiple sclerosis (MS) that would enable patients to rank their disability relative to others9 with similar disease duration and to develop a cost-effective research tool for comparing MS severity across patient populations and time periods. Methods: The North American Research Committee on Multiple Sclerosis (NARCOMS) Registry collects disability data from patients with MS on a validated, 9-point Patient-Determined Disease Steps (PDDS) scale. We compiled the Disability Expectancy Table, which displays cumulative frequencies of PDDS scores for each year of disease duration, from 0 to 45 years. We also tabulated disease duration–adjusted mean ranks of PDDS scores, referred to as Patient-derived MS Severity Scores (P-MSSS). Results: The cohort consisted of 27,918 NARCOMS enrollees, 72.7% of whom were female and 90.1% of whom were white. Mean age at symptom onset was 30.1 ± 10.1 years, and age at enrollment was 47.1 ± 11.0 years. The Disability Expectancy Table and P-MSSS afford a detailed overview of disability outcomes in a large MS cohort over a 45-year period. In the first year of disease, 15% of patients reported need of ambulatory aid, and 4% needed bilateral assistance or worse; after 45 years of disease, 76% of patients required ambulatory aid, and 52% bilateral assistance or worse. Proportion of patients who reported minimal or no interference in daily activities (PDDS ≤ 1) declined from 63% in the first year to 8% after 45 years of disease. Conclusion: The Disability Expectancy Table allows individual patients to determine how their disability ranks relative to NARCOMS enrollees with the same disease duration. P-MSSS may be used to compare disability across patient populations and to track disease progression in patient cohorts. P-MSSS does not require a formal neurologic examination and may therefore find wide applicability as a practical and cost-effective outcome measure in epidemiologic studies.Keywords
This publication has 26 references indexed in Scilit:
- A representative cohort of patients with non-progressive multiple sclerosis at the age of normal life expectancyBrain, 2012
- Genome-wide association study of severity in multiple sclerosisGenes & Immunity, 2011
- Rapid disease course in African Americans with multiple sclerosisNeurology, 2010
- Long-term clinical relevance of criteria for designating multiple sclerosis as benign after 10 years of diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2008
- Validation of the NARCOMS registry: diagnosisMultiple Sclerosis Journal, 2007
- A profile of multiple sclerosis: The New York State Multiple Sclerosis ConsortiumMultiple Sclerosis Journal, 1999
- Disease steps in multiple sclerosis: a longitudinal study comparing Disease Steps and EDSS to evaluate disease progressionMultiple Sclerosis Journal, 1999
- The NARCOMS Patient Registry: A Resource for InvestigatorsInternational Journal of MS Care, 1999
- Disease Steps in multiple sclerosisNeurology, 1995
- Statistical Methods in Cancer Research, Volume II: The Design and Analysis of Cohort Studies.Journal of the American Statistical Association, 1992